Enovis Aims to Change the Game for Shoulder Surgeons

Following Enovis’ acquisition of LimaCorporate, the company is on pace for $1 billion in annual reconstructive sales. With much excitement from the Lima acquisition, Enovis is aligning a series of innovative offerings to leverage its new scale in fast-growing markets.

To learn more about the opportunities before the company, we spoke to...

document icon

You’ve reached your limit.

We’re glad you’re finding value in our content — and we’d love for you to keep going.

Subscribe now for unlimited access to orthopedic business intelligence.

ME

Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.



Contact Us

0